Alternatives to Blood Transfusion in Transfusion Medicine
Eds.: Maniatis, Alice; Van der Linden, Phillipe; Hardy, Jean-François
Alternatives to Blood Transfusion in Transfusion Medicine
Eds.: Maniatis, Alice; Van der Linden, Phillipe; Hardy, Jean-François
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Meeting the needs of patients while minimizing blood transfusions requires special expertise, precise monitoring and innovative techniques. This cutting-edge resource covers all the important clinical aspects of transfusion medicine in diverse clinical settings, with a special emphasis on alternatives to transfusion. Edited by a multidisciplinary team consisting of a transfusion specialist, an anesthesiologist and an intensive care specialist this book is endorsed by the Network for Advancement of Transfusion Alternatives. The contributors review the appropriate use of fluids and of blood…mehr
Andere Kunden interessierten sich auch für
- Harvey G. KleinMollison's Blood Transfusion in Clinical Medicine199,99 €
- Petra SeeberBasics of Blood Management121,99 €
- Hemovigilance167,99 €
- Current and Future Issues in Hemophilia Care110,99 €
- Tissue and Cell Donation153,99 €
- Cooley's Anemia152,99 €
- Margaret C FangInpatient Anticoagulation84,99 €
-
-
-
Meeting the needs of patients while minimizing blood transfusions requires special expertise, precise monitoring and innovative techniques. This cutting-edge resource covers all the important clinical aspects of transfusion medicine in diverse clinical settings, with a special emphasis on alternatives to transfusion.
Edited by a multidisciplinary team consisting of a transfusion specialist, an anesthesiologist and an intensive care specialist this book is endorsed by the Network for Advancement of Transfusion Alternatives. The contributors review the appropriate use of fluids and of blood products, and describe the latest treatment options available to decrease the need for allogeneic blood products including:
Argon beam
Cell saver
Harmonic scalpel
Normovolemic haemodilution
Synthetic erythropoietin
Antifibrinolytics
Recombinant factor VIIa
Advanced monitoring of hemostasis
Intravenous iron
The new edition is a key reference source for all those involved in the practice of blood management and conservation.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Edited by a multidisciplinary team consisting of a transfusion specialist, an anesthesiologist and an intensive care specialist this book is endorsed by the Network for Advancement of Transfusion Alternatives. The contributors review the appropriate use of fluids and of blood products, and describe the latest treatment options available to decrease the need for allogeneic blood products including:
Argon beam
Cell saver
Harmonic scalpel
Normovolemic haemodilution
Synthetic erythropoietin
Antifibrinolytics
Recombinant factor VIIa
Advanced monitoring of hemostasis
Intravenous iron
The new edition is a key reference source for all those involved in the practice of blood management and conservation.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Wiley & Sons / Wiley-Blackwell
- Artikelnr. des Verlages: 1A405163210
- 2. Aufl.
- Seitenzahl: 606
- Erscheinungstermin: 23. November 2010
- Englisch
- Abmessung: 253mm x 199mm x 33mm
- Gewicht: 1475g
- ISBN-13: 9781405163217
- ISBN-10: 1405163216
- Artikelnr.: 28776753
- Verlag: Wiley & Sons / Wiley-Blackwell
- Artikelnr. des Verlages: 1A405163210
- 2. Aufl.
- Seitenzahl: 606
- Erscheinungstermin: 23. November 2010
- Englisch
- Abmessung: 253mm x 199mm x 33mm
- Gewicht: 1475g
- ISBN-13: 9781405163217
- ISBN-10: 1405163216
- Artikelnr.: 28776753
Professor Alice Maniatis, Haematology Department of Internal Medicine, University of Greece, Athens, Greece and former President of Network for Advancement of Transfusion Alternatives (NATA). Dr Jean-Francois Hardy, Department of Anesthesia, Montreal Heart Institute, Quebec, Canada and on the Board of Directors of NATA. Dr Phillipe van der Linden, Department of Anesthesiology and Intensive Care, Brussels, Belguim and on the Board of Directors of NATA.
List of Contributors. Preface. Section 1: History and Development of
Transfusion Medicine. 1 From blood transfusion to transfusion medicine
(Alice Maniatis). Section 2: Allogeneic Blood Usage -- Risks and Benefits.
2 Allogeneic Blood Components (Rebecca Cardigan & Sheila MacLennan). 3
Current Information on the Infectious Risks of Allogeneic Blood Transfusion
(A. Kitchen and J. Barbara). 4 Immunological Complications of Transfusion
(Clare Taylor, Cristina Navarrete, Marcela Contreras). 5 Immunomodulation
and Allogeneic Transfusion (M. Waanders, L. van de Watering, A. Brand). 6
Pathogen Inactivation (of Blood Components) (Chris Prowse). 7 The Benefits
of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have? (Neil Soni
and Benjamin Thomas). Section 3: Volume Replacement. Part 1. Plasma and
Albumin. 8 Plasma and Albumin (P. Baele). Part 2. Crystalloids and
Synthetic Colloids. 9 Pharmacology of Intravenous Fluids (Michael F. M.
James). 10 Crystalloids Versus Colloids: The Controversy (H. Haljamäe). 11
Effects of Synthetic Colloids on Hemostasis (Sibylle A. Kozek-Langenecker,
Gisela Scharbert). 12 Hydroxyethyl starch and renal dysfunction (Laurent
Jacob, Nicholas Heming & Bertrand Guidet). 13 Choice of a Synthetic Colloid
for Surgery (J. Boldt). 14 Choice of a Colloid for Intensive Care Patients
(Y. Sakr, Y. Inel). 15 Hypertonic Saline Solutions for the Initial
Treatment of Patients with Traumatic Injuries (Charles E. Wade and Michael
A. Dubick). 16 Hyperchloremic Acidosis (Edward Burdett and Andre Vercueil).
Section 4: Tolerance of Anemia. 17 Basic Principles of Oxygen Transport and
Calculations (Jean-Louis Vincent, Pongdhep Theerawit and Davide Simion). 18
Assessment of Tissue Oxygenation (Michael Piagnerelli, Ann Dierick and
Philippe Van der Linden). 19 Tissue Oxygenation and Blood Transfusion
(Stefan Suttner and Joachim Boldt). 20 Anemia and Cardiovascular Disease
(Antonis S. Manolis, Spyridon Koulouris, Kostas Triantafyllou, Dimitris
Sakellariou, Sokratis Pastromas, Helen Melita). Section 5: Perioperative
Hemostasis. 21 Monitoring of Hemostasis in the Perioperative Setting
(Sibylle A. Kozek-Langenecker). 22 Antifibrinolytics in open heart surgery
(Wulf Dietrich). 23 Efficacy and Safety of Recombinant Activated Factor VII
to Control Bleeding in Non-hemophiliac Patients (Jean-François Hardy,
Sylvain Bélisle, Philippe Van der Linden). Section 6: Transfusion Triggers.
24 Role of Hemoglobin/Hematocrit (Kristine J. Guleserian, Hae W. Kim, Bruce
Pearce, Arkadiy Pitman, A. Gerson Greenburg). 25 Calculation of Blood Loss
(Mark E. Brecher). 26 Management of massive transfusion (Jean-François
Hardy and Marc Samama). Section 7: Alternatives to Allogeneic Blood
Transfusion. Part 1. Pharmaceutical Approaches. 27 Iron deficiency: causes,
diagnosis and management (Manuel Muñoz, José Antonio García-Erce, Elvira
Bisbe). 28 Current Status of Perisurgical Erythropoietin Therapy (Lawrence
T. Goodnough). 29 Erythropoietin and Iron Therapy in Patients with Renal
Failure (Lucia Del Vecchio and Francesco Locatelli). Oxygen Carriers. 30
Hemoglobin-Based Blood Substitutes (G. Deby-Dupont, M. Lamy, B. Rémy). 31
Perfluorocarbon Emulsions (Pedro Cabrales). Part 2. Surgical Techniques. 32
Minimally Invasive Cardiac Surgery: Impact on Blood Loss and Transfusion
(He Tao and Fraser Rubens). 33 Adjunctive Strategies to Impact Blood
Transfusion in Cardiac Surgery (L. Ressler and Fraser Rubens). Part 3.
Anesthetic Techniques. 34 Anesthetic Techniques to Reduce Blood Loss
(Dafydd Thomas). 35 Controlled Hypotension Decreases Blood Transfusion
Requirement: Fact or Fallacy? (Richard P. Dutton). 36 Acute Normovolemic
Hemodilution (Javad Bidgoli and Philippe Van der linden). 37 Hyperoxic
Hemodilution (Jens Meier, Konrad Messmer, Oliver Habler). 38 Intraoperative
and Postoperative Cell Salvage (Ernil Hansen, Hans Gombotz). Part 4.
Special Settings. 39 Anemia and Red Blood Cell Transfusion in Critical Care
(Timothy Walsh). 40 Red Blood Cell Transfusions and Alternatives to Treat
the Anemia of Prematurity (Ronald G. Strauss). 41 Transfusion Alternatives
in Orthopedic Surgery (Manuel Muñoz, José Antonio García-Erce, Jorge
Cuenca). 42 Transfusion Alternatives in Obstetrics (Christian Breymann).
Section 8: Legal and Ethical Issues in Transfusion Medicine. 43 Ethical
Aspects of Informed Consent: American Models (Ronald E. Domen). 44 Blood
Transfusions, Jehovah's Witnesses and the American Patients' Rights
Movement (Charles H. Baron). Section 9: Cost Issues. 45 The Cost and Cost
Effectiveness of Allogeneic and Autologous Blood (Brian Custer). 46
Autologous Blood Predonation in Cardiac Surgery (Wulf Dietrich). 47
Cost-Effectiveness of Pharmacological Alternatives (Dean Fergusson and
Brian Hutton).
Transfusion Medicine. 1 From blood transfusion to transfusion medicine
(Alice Maniatis). Section 2: Allogeneic Blood Usage -- Risks and Benefits.
2 Allogeneic Blood Components (Rebecca Cardigan & Sheila MacLennan). 3
Current Information on the Infectious Risks of Allogeneic Blood Transfusion
(A. Kitchen and J. Barbara). 4 Immunological Complications of Transfusion
(Clare Taylor, Cristina Navarrete, Marcela Contreras). 5 Immunomodulation
and Allogeneic Transfusion (M. Waanders, L. van de Watering, A. Brand). 6
Pathogen Inactivation (of Blood Components) (Chris Prowse). 7 The Benefits
of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have? (Neil Soni
and Benjamin Thomas). Section 3: Volume Replacement. Part 1. Plasma and
Albumin. 8 Plasma and Albumin (P. Baele). Part 2. Crystalloids and
Synthetic Colloids. 9 Pharmacology of Intravenous Fluids (Michael F. M.
James). 10 Crystalloids Versus Colloids: The Controversy (H. Haljamäe). 11
Effects of Synthetic Colloids on Hemostasis (Sibylle A. Kozek-Langenecker,
Gisela Scharbert). 12 Hydroxyethyl starch and renal dysfunction (Laurent
Jacob, Nicholas Heming & Bertrand Guidet). 13 Choice of a Synthetic Colloid
for Surgery (J. Boldt). 14 Choice of a Colloid for Intensive Care Patients
(Y. Sakr, Y. Inel). 15 Hypertonic Saline Solutions for the Initial
Treatment of Patients with Traumatic Injuries (Charles E. Wade and Michael
A. Dubick). 16 Hyperchloremic Acidosis (Edward Burdett and Andre Vercueil).
Section 4: Tolerance of Anemia. 17 Basic Principles of Oxygen Transport and
Calculations (Jean-Louis Vincent, Pongdhep Theerawit and Davide Simion). 18
Assessment of Tissue Oxygenation (Michael Piagnerelli, Ann Dierick and
Philippe Van der Linden). 19 Tissue Oxygenation and Blood Transfusion
(Stefan Suttner and Joachim Boldt). 20 Anemia and Cardiovascular Disease
(Antonis S. Manolis, Spyridon Koulouris, Kostas Triantafyllou, Dimitris
Sakellariou, Sokratis Pastromas, Helen Melita). Section 5: Perioperative
Hemostasis. 21 Monitoring of Hemostasis in the Perioperative Setting
(Sibylle A. Kozek-Langenecker). 22 Antifibrinolytics in open heart surgery
(Wulf Dietrich). 23 Efficacy and Safety of Recombinant Activated Factor VII
to Control Bleeding in Non-hemophiliac Patients (Jean-François Hardy,
Sylvain Bélisle, Philippe Van der Linden). Section 6: Transfusion Triggers.
24 Role of Hemoglobin/Hematocrit (Kristine J. Guleserian, Hae W. Kim, Bruce
Pearce, Arkadiy Pitman, A. Gerson Greenburg). 25 Calculation of Blood Loss
(Mark E. Brecher). 26 Management of massive transfusion (Jean-François
Hardy and Marc Samama). Section 7: Alternatives to Allogeneic Blood
Transfusion. Part 1. Pharmaceutical Approaches. 27 Iron deficiency: causes,
diagnosis and management (Manuel Muñoz, José Antonio García-Erce, Elvira
Bisbe). 28 Current Status of Perisurgical Erythropoietin Therapy (Lawrence
T. Goodnough). 29 Erythropoietin and Iron Therapy in Patients with Renal
Failure (Lucia Del Vecchio and Francesco Locatelli). Oxygen Carriers. 30
Hemoglobin-Based Blood Substitutes (G. Deby-Dupont, M. Lamy, B. Rémy). 31
Perfluorocarbon Emulsions (Pedro Cabrales). Part 2. Surgical Techniques. 32
Minimally Invasive Cardiac Surgery: Impact on Blood Loss and Transfusion
(He Tao and Fraser Rubens). 33 Adjunctive Strategies to Impact Blood
Transfusion in Cardiac Surgery (L. Ressler and Fraser Rubens). Part 3.
Anesthetic Techniques. 34 Anesthetic Techniques to Reduce Blood Loss
(Dafydd Thomas). 35 Controlled Hypotension Decreases Blood Transfusion
Requirement: Fact or Fallacy? (Richard P. Dutton). 36 Acute Normovolemic
Hemodilution (Javad Bidgoli and Philippe Van der linden). 37 Hyperoxic
Hemodilution (Jens Meier, Konrad Messmer, Oliver Habler). 38 Intraoperative
and Postoperative Cell Salvage (Ernil Hansen, Hans Gombotz). Part 4.
Special Settings. 39 Anemia and Red Blood Cell Transfusion in Critical Care
(Timothy Walsh). 40 Red Blood Cell Transfusions and Alternatives to Treat
the Anemia of Prematurity (Ronald G. Strauss). 41 Transfusion Alternatives
in Orthopedic Surgery (Manuel Muñoz, José Antonio García-Erce, Jorge
Cuenca). 42 Transfusion Alternatives in Obstetrics (Christian Breymann).
Section 8: Legal and Ethical Issues in Transfusion Medicine. 43 Ethical
Aspects of Informed Consent: American Models (Ronald E. Domen). 44 Blood
Transfusions, Jehovah's Witnesses and the American Patients' Rights
Movement (Charles H. Baron). Section 9: Cost Issues. 45 The Cost and Cost
Effectiveness of Allogeneic and Autologous Blood (Brian Custer). 46
Autologous Blood Predonation in Cardiac Surgery (Wulf Dietrich). 47
Cost-Effectiveness of Pharmacological Alternatives (Dean Fergusson and
Brian Hutton).
List of Contributors. Preface. Section 1: History and Development of
Transfusion Medicine. 1 From blood transfusion to transfusion medicine
(Alice Maniatis). Section 2: Allogeneic Blood Usage -- Risks and Benefits.
2 Allogeneic Blood Components (Rebecca Cardigan & Sheila MacLennan). 3
Current Information on the Infectious Risks of Allogeneic Blood Transfusion
(A. Kitchen and J. Barbara). 4 Immunological Complications of Transfusion
(Clare Taylor, Cristina Navarrete, Marcela Contreras). 5 Immunomodulation
and Allogeneic Transfusion (M. Waanders, L. van de Watering, A. Brand). 6
Pathogen Inactivation (of Blood Components) (Chris Prowse). 7 The Benefits
of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have? (Neil Soni
and Benjamin Thomas). Section 3: Volume Replacement. Part 1. Plasma and
Albumin. 8 Plasma and Albumin (P. Baele). Part 2. Crystalloids and
Synthetic Colloids. 9 Pharmacology of Intravenous Fluids (Michael F. M.
James). 10 Crystalloids Versus Colloids: The Controversy (H. Haljamäe). 11
Effects of Synthetic Colloids on Hemostasis (Sibylle A. Kozek-Langenecker,
Gisela Scharbert). 12 Hydroxyethyl starch and renal dysfunction (Laurent
Jacob, Nicholas Heming & Bertrand Guidet). 13 Choice of a Synthetic Colloid
for Surgery (J. Boldt). 14 Choice of a Colloid for Intensive Care Patients
(Y. Sakr, Y. Inel). 15 Hypertonic Saline Solutions for the Initial
Treatment of Patients with Traumatic Injuries (Charles E. Wade and Michael
A. Dubick). 16 Hyperchloremic Acidosis (Edward Burdett and Andre Vercueil).
Section 4: Tolerance of Anemia. 17 Basic Principles of Oxygen Transport and
Calculations (Jean-Louis Vincent, Pongdhep Theerawit and Davide Simion). 18
Assessment of Tissue Oxygenation (Michael Piagnerelli, Ann Dierick and
Philippe Van der Linden). 19 Tissue Oxygenation and Blood Transfusion
(Stefan Suttner and Joachim Boldt). 20 Anemia and Cardiovascular Disease
(Antonis S. Manolis, Spyridon Koulouris, Kostas Triantafyllou, Dimitris
Sakellariou, Sokratis Pastromas, Helen Melita). Section 5: Perioperative
Hemostasis. 21 Monitoring of Hemostasis in the Perioperative Setting
(Sibylle A. Kozek-Langenecker). 22 Antifibrinolytics in open heart surgery
(Wulf Dietrich). 23 Efficacy and Safety of Recombinant Activated Factor VII
to Control Bleeding in Non-hemophiliac Patients (Jean-François Hardy,
Sylvain Bélisle, Philippe Van der Linden). Section 6: Transfusion Triggers.
24 Role of Hemoglobin/Hematocrit (Kristine J. Guleserian, Hae W. Kim, Bruce
Pearce, Arkadiy Pitman, A. Gerson Greenburg). 25 Calculation of Blood Loss
(Mark E. Brecher). 26 Management of massive transfusion (Jean-François
Hardy and Marc Samama). Section 7: Alternatives to Allogeneic Blood
Transfusion. Part 1. Pharmaceutical Approaches. 27 Iron deficiency: causes,
diagnosis and management (Manuel Muñoz, José Antonio García-Erce, Elvira
Bisbe). 28 Current Status of Perisurgical Erythropoietin Therapy (Lawrence
T. Goodnough). 29 Erythropoietin and Iron Therapy in Patients with Renal
Failure (Lucia Del Vecchio and Francesco Locatelli). Oxygen Carriers. 30
Hemoglobin-Based Blood Substitutes (G. Deby-Dupont, M. Lamy, B. Rémy). 31
Perfluorocarbon Emulsions (Pedro Cabrales). Part 2. Surgical Techniques. 32
Minimally Invasive Cardiac Surgery: Impact on Blood Loss and Transfusion
(He Tao and Fraser Rubens). 33 Adjunctive Strategies to Impact Blood
Transfusion in Cardiac Surgery (L. Ressler and Fraser Rubens). Part 3.
Anesthetic Techniques. 34 Anesthetic Techniques to Reduce Blood Loss
(Dafydd Thomas). 35 Controlled Hypotension Decreases Blood Transfusion
Requirement: Fact or Fallacy? (Richard P. Dutton). 36 Acute Normovolemic
Hemodilution (Javad Bidgoli and Philippe Van der linden). 37 Hyperoxic
Hemodilution (Jens Meier, Konrad Messmer, Oliver Habler). 38 Intraoperative
and Postoperative Cell Salvage (Ernil Hansen, Hans Gombotz). Part 4.
Special Settings. 39 Anemia and Red Blood Cell Transfusion in Critical Care
(Timothy Walsh). 40 Red Blood Cell Transfusions and Alternatives to Treat
the Anemia of Prematurity (Ronald G. Strauss). 41 Transfusion Alternatives
in Orthopedic Surgery (Manuel Muñoz, José Antonio García-Erce, Jorge
Cuenca). 42 Transfusion Alternatives in Obstetrics (Christian Breymann).
Section 8: Legal and Ethical Issues in Transfusion Medicine. 43 Ethical
Aspects of Informed Consent: American Models (Ronald E. Domen). 44 Blood
Transfusions, Jehovah's Witnesses and the American Patients' Rights
Movement (Charles H. Baron). Section 9: Cost Issues. 45 The Cost and Cost
Effectiveness of Allogeneic and Autologous Blood (Brian Custer). 46
Autologous Blood Predonation in Cardiac Surgery (Wulf Dietrich). 47
Cost-Effectiveness of Pharmacological Alternatives (Dean Fergusson and
Brian Hutton).
Transfusion Medicine. 1 From blood transfusion to transfusion medicine
(Alice Maniatis). Section 2: Allogeneic Blood Usage -- Risks and Benefits.
2 Allogeneic Blood Components (Rebecca Cardigan & Sheila MacLennan). 3
Current Information on the Infectious Risks of Allogeneic Blood Transfusion
(A. Kitchen and J. Barbara). 4 Immunological Complications of Transfusion
(Clare Taylor, Cristina Navarrete, Marcela Contreras). 5 Immunomodulation
and Allogeneic Transfusion (M. Waanders, L. van de Watering, A. Brand). 6
Pathogen Inactivation (of Blood Components) (Chris Prowse). 7 The Benefits
of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have? (Neil Soni
and Benjamin Thomas). Section 3: Volume Replacement. Part 1. Plasma and
Albumin. 8 Plasma and Albumin (P. Baele). Part 2. Crystalloids and
Synthetic Colloids. 9 Pharmacology of Intravenous Fluids (Michael F. M.
James). 10 Crystalloids Versus Colloids: The Controversy (H. Haljamäe). 11
Effects of Synthetic Colloids on Hemostasis (Sibylle A. Kozek-Langenecker,
Gisela Scharbert). 12 Hydroxyethyl starch and renal dysfunction (Laurent
Jacob, Nicholas Heming & Bertrand Guidet). 13 Choice of a Synthetic Colloid
for Surgery (J. Boldt). 14 Choice of a Colloid for Intensive Care Patients
(Y. Sakr, Y. Inel). 15 Hypertonic Saline Solutions for the Initial
Treatment of Patients with Traumatic Injuries (Charles E. Wade and Michael
A. Dubick). 16 Hyperchloremic Acidosis (Edward Burdett and Andre Vercueil).
Section 4: Tolerance of Anemia. 17 Basic Principles of Oxygen Transport and
Calculations (Jean-Louis Vincent, Pongdhep Theerawit and Davide Simion). 18
Assessment of Tissue Oxygenation (Michael Piagnerelli, Ann Dierick and
Philippe Van der Linden). 19 Tissue Oxygenation and Blood Transfusion
(Stefan Suttner and Joachim Boldt). 20 Anemia and Cardiovascular Disease
(Antonis S. Manolis, Spyridon Koulouris, Kostas Triantafyllou, Dimitris
Sakellariou, Sokratis Pastromas, Helen Melita). Section 5: Perioperative
Hemostasis. 21 Monitoring of Hemostasis in the Perioperative Setting
(Sibylle A. Kozek-Langenecker). 22 Antifibrinolytics in open heart surgery
(Wulf Dietrich). 23 Efficacy and Safety of Recombinant Activated Factor VII
to Control Bleeding in Non-hemophiliac Patients (Jean-François Hardy,
Sylvain Bélisle, Philippe Van der Linden). Section 6: Transfusion Triggers.
24 Role of Hemoglobin/Hematocrit (Kristine J. Guleserian, Hae W. Kim, Bruce
Pearce, Arkadiy Pitman, A. Gerson Greenburg). 25 Calculation of Blood Loss
(Mark E. Brecher). 26 Management of massive transfusion (Jean-François
Hardy and Marc Samama). Section 7: Alternatives to Allogeneic Blood
Transfusion. Part 1. Pharmaceutical Approaches. 27 Iron deficiency: causes,
diagnosis and management (Manuel Muñoz, José Antonio García-Erce, Elvira
Bisbe). 28 Current Status of Perisurgical Erythropoietin Therapy (Lawrence
T. Goodnough). 29 Erythropoietin and Iron Therapy in Patients with Renal
Failure (Lucia Del Vecchio and Francesco Locatelli). Oxygen Carriers. 30
Hemoglobin-Based Blood Substitutes (G. Deby-Dupont, M. Lamy, B. Rémy). 31
Perfluorocarbon Emulsions (Pedro Cabrales). Part 2. Surgical Techniques. 32
Minimally Invasive Cardiac Surgery: Impact on Blood Loss and Transfusion
(He Tao and Fraser Rubens). 33 Adjunctive Strategies to Impact Blood
Transfusion in Cardiac Surgery (L. Ressler and Fraser Rubens). Part 3.
Anesthetic Techniques. 34 Anesthetic Techniques to Reduce Blood Loss
(Dafydd Thomas). 35 Controlled Hypotension Decreases Blood Transfusion
Requirement: Fact or Fallacy? (Richard P. Dutton). 36 Acute Normovolemic
Hemodilution (Javad Bidgoli and Philippe Van der linden). 37 Hyperoxic
Hemodilution (Jens Meier, Konrad Messmer, Oliver Habler). 38 Intraoperative
and Postoperative Cell Salvage (Ernil Hansen, Hans Gombotz). Part 4.
Special Settings. 39 Anemia and Red Blood Cell Transfusion in Critical Care
(Timothy Walsh). 40 Red Blood Cell Transfusions and Alternatives to Treat
the Anemia of Prematurity (Ronald G. Strauss). 41 Transfusion Alternatives
in Orthopedic Surgery (Manuel Muñoz, José Antonio García-Erce, Jorge
Cuenca). 42 Transfusion Alternatives in Obstetrics (Christian Breymann).
Section 8: Legal and Ethical Issues in Transfusion Medicine. 43 Ethical
Aspects of Informed Consent: American Models (Ronald E. Domen). 44 Blood
Transfusions, Jehovah's Witnesses and the American Patients' Rights
Movement (Charles H. Baron). Section 9: Cost Issues. 45 The Cost and Cost
Effectiveness of Allogeneic and Autologous Blood (Brian Custer). 46
Autologous Blood Predonation in Cardiac Surgery (Wulf Dietrich). 47
Cost-Effectiveness of Pharmacological Alternatives (Dean Fergusson and
Brian Hutton).